CD40 is functionally expressed on human breast carcinomas: Variable inducibility by cytokines and enhancement of Fas-mediated apoptosis

Breast Cancer Research and Treatment

Volumn 50, Issue 1, 1998, Pages 27-36

  Wingett, Denise G ^a   Vestal, Robert E ^a,b   Forcier, Kristin ^a   Hadjokas, Nicholas ^a   Nielson, Christopher P ^a,b  

^a Boise VA Medical Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apoptosis; Breast neoplasms; Carcinoma; CD40; Fas; IFN

Indexed keywords

CD40 ANTIGEN; CYTOKINE; FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BREAST CARCINOMA; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RECEPTOR GENE; SIGNAL TRANSDUCTION;

ANTIGENS, CD40; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031788449     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006012607452     Document Type: Article

References (42)

1. Cleveland JL, Ihle JN: Contenders in FasL/TNF death signaling. Cell 81: 479-482, 1995
2. Baker SJ, Reedy EP: Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12: 1-9, 1996
3. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962, 1994
4. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243, 1991
5. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845-853, 1993
6. Stamenkovic I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8: 1403-1410, 1989
7. Hess S, Englemann H: A novel function of CD40: Induction of cell death in transformed cells. J Exp Med 183: 159-167, 1996
8. Eliopoulos AG, Dawson CW, Mosialos G, Floettmann JE, Rowe M, Armitage RJ, Dawson J, Zapata JM, Kerr DJ, Wakelam MJO, Reed JC, Kiefl E, Young LS: CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene 13: 2243-2254, 1996
9. Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, Fanslow WC: Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur J Immunol 23: 2368-2371, 1993
10. Lederman S, Yellin MJ, Cleary AM, Pernis A, Inghirami G, Cohn LE, Covey LR, Lee JJ, Rothman P, Chess L: T-BAM/ CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype Switch recombination and rescues B cells from programmed cell death. J Immunol 152: 2163-2171, 1994
11. Lens SM, Tesselaar K, den Drijver BFA, van Oers MHJ, van Lier RAW: A dual role for both CD40-ligand and TNF-α in controlling human B cell death. J Immunol 156: 507-514, 1996
12. Banchereau J, de-Paoli P, Valle A, Garcia E, Rousset F: Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251: 70-72, 1991
13. Jumper MD, Nishioka Y, Davis LS, Lipsky PE, Meek K: Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands. J Immunol 155: 2369-2378, 1995
14. Jabara HH, Fu SM, Geha RS, Vercelli D: CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 172: 1861-1864, 1990
15. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal leukemic B cells through a CD40-dependent signal. J Exp Med 177: 925-935, 1993
16. Roy M, Aruffo A, Ledbetter J, Linsley P, Kehry M, Noelle R: Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol 25: 596-603, 1995
17. O'Doherty U, Steinman RM, Peng M, Cameron PU, Gezelter S, Kopeloff I, Swiggard WJ, Pope M, Bhardwaj M: Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med 178: 1067-1076, 1993
18. Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G: Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur J Immunol 25: 1943-1950, 1995
19. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK: CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178: 669-674, 1993
20. Fries KM, Sempowski GD, Gaspari AA, Blieden T, Looney RJ, Phipps RP: CD40 expression by human fibroblasts. Clin Immunol Immunopathol 77: 42-51, 1995
21. Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober JS: CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 92: 4342-4346, 1995
22. Young LS, Dawson CW, Brown KW, Rickinson AB: Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int J Cancer 43: 786-794, 1989
23. Galy AH, Spits H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 149: 775-782, 1992
24. Paulie S, Ehlin-Henriksson B, Mellstedt H, Koho H, Ben-Aissa H, Perlmann P: A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother 20: 23-28, 1985
25. Paulie S, Rosen A, Ehlin-Henriksson B, Braesch-Anderson S, Jakobson E, Koho H, Perlmann P: The human B lymphocyte and carcinoma antigen, CD40, is a phosphoprotein involved in growth signal transduction. J Immunol 142: 590-595, 1989
26. Koho H, Paulie S, Ben-Aissa H, Jonsdottir I, Hansson Y, Lundblad ML, Perlmann P: Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. 1. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence. Cancer Immunol Immunother 17: 165-172, 1984
27. Brodie C, Gelfand EW: Regulation of immunoglobulin production by nerve growth factor: Comparison with anti-CD40. J Neuroimmunol 52: 87-96, 1994
28. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A: A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 89: 6550-6554, 1992
29. Regnier CH, Tomasetto C, Moog-Lutz C, Chenard MP, Wendling C, Basset P, Rio MC: Presence of a new conserved domain in CART1, a novel member of the Tumor Necrosis Factor Receptor-associated protein family, which is expressed in breast carcinoma. J Biol Chem 270: 25715-25721, 1996
30. Guardiola J, Maffei A: Control of MHC class II gene expression in autoimmune, infectious, and neoplastic disease. Crit Rev Immunol 13: 247-268, 1993
31. Sharpe JC, Abel PD, Gilbertson JA, Brawn P, Foster CS: Modulated expression of human leukocyte antigen class I and class II determinants in hyperplastic and malignant human prostatic epithelium. Br J Urol 74: 609-616, 1994
32. Blades RA, Keating PJ, McWilliam LJ, George MJR, Stern PL: Loss of HLA class I expression in prostate cancer: implications for immunotherapy. Urology 46: 681-687, 1995
33. Hasbold J, Johnson-Leger C, Atkins CJ, Clark EA, Klaus GGB: Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur J Immunol 24: 1835-1842, 1994
34. Lu Y, Ussery GD, Muncaster MM, Gallie BL, Blanck G: Evidence for retinoblastoma protein (RB) dependent and independent IFN-γ responses: RB coordinated rescues IFN-γ induction of MHC class II gene transcription in noninducible breast carcinoma cells. Oncogene 9: 1015-1019, 1994
35. Kenne MM, Etterberg SA, Lowrey GA, Russell EK, Lipkowitz S: Fas expression and function in normal and malignant breast cell lines. Cancer Res 56: 4791-4798, 1996
36. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH, Moller P: Constitutive and induced expression of apo-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and malignant cells. Lab Invest 69: 415-429, 1993
37. Schattner EJ, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, Friedman SM: CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182: 1557-1565, 1995
38. Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J: Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182: 1265-1273, 1995
39. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC: Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87: 319-329, 1996
40. Cromme FV, Van-Bommel PF, Walboomers JM, Gallee MP, Stern PL, Kenemans P, Helmerhorst TJ, Stukart MJ, Meijer CJ: Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br J Cancer 69: 1176-1181, 1994
41. Baskar S, Azarenko V, Garcia-Marshall E, Hughes F, Ostrand-Rosenberg S: MHC class II-transfected tumor cells induce long-term tumor-specific immunity in autologous mice. Cell Immunol 155: 123-133, 1994
42. Hock RA, Reynolds BD, Tucker-McClung CL, Kowk WW: Human class II major histocompatibility complex gene transfer into murine neuroblastoma leads to loss of tumorigenicity, immunity against subsequent tumor challenge, and elimination of microscopic preestablished tumors. J Immunother Emphasis Tumor Immunol 17: 12-18, 1995